some of the posts on here. Compare, again, KDR and FFX:
KDR SQM JV deal, in Western Australia, 2017 when LCE was 140K USD+
FFX Ganfeng JV deal, in Western Africa, LCE at 89K USD:
The Mt Holland resource is almost twice the size of Goulamina and similar grade:
I think the deal is GOOD, all things considered.
ICYMI: Within two years of KDR-SQM deal:
valuing the project at $1.55B in 2019, when LCE was 75-80K.
Ganfeng is paying more than SQM did for a 40-45% share (depending on what share the Mali govt opts for) of a smaller resource in Africa with no downstream element AND is taking 50-100% of offtake for the Life of Mine (!) AND will organise debt financing if necessary.
Here's a chart of KDR following the SQM deal (grabbed from my earlier post regarding this). Shareholders wanted Martin Donohue's head on a platter in the short term. Fortunately Jacobin justice did not prevail.
- Forums
- ASX - By Stock
- FFX
- Ann: Live investor briefing
Ann: Live investor briefing, page-59
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online